A review on potential of PARP inhibitors in the treatment of prostate cancer

A review on potential of PARP inhibitors in the treatment of prostate cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Bibliographische Detailangaben
1. Verfasser:	Islam, Saidul
Weitere Verfasser:	Sharmin, Shahana
Format:	Abschlussarbeit
Sprache:	English
Veröffentlicht:	Brac University 2022
Schlagworte:	Prostate cancer Therapeutic approaches mCRPC PARP inhibitors Olaparib Cancer > Treatment Enzyme inhibitors > Therapeutic use Cancer > Gene therapy
Online Zugang:	http://hdl.handle.net/10361/17308

Ähnliche Einträge

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
von: Karim, Azrin
Veröffentlicht: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
von: Flora, Sanzida Alam
Veröffentlicht: (2024)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
von: Meem, Manila
Veröffentlicht: (2023)

Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies
von: Alam, Tahera
Veröffentlicht: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
von: Jahan, Nusrat
Veröffentlicht: (2024)

Association of XRCC1 and XPD polymorphism with risk of prostate cancer in Bangladesh population
von: Ahmed, Nafisa
Veröffentlicht: (2023)

Immunotherapy in the Management of Lung Cancer
von: Tasnim, Humayra
Veröffentlicht: (2022)

A review on triple-negative breast cancer and its potential treatment
von: Niasa, Jannatul Ferdous
Veröffentlicht: (2023)

Stem cells as therapeutic carrier in cancer treatment
von: Anika, Mysha Yeasmin
Veröffentlicht: (2022)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
von: Hasan, Amit
Veröffentlicht: (2024)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
von: Chakraborty, Anuradha
Veröffentlicht: (2024)

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
von: Khan, Muidul Hasan
Veröffentlicht: (2024)

A review on potential role of cannabinoids as therapeutic agents in different types of cancer
von: Roy, Hredita
Veröffentlicht: (2018)

Recent advances in Cancer treatment targeting autophagy and future aspects
von: Emon, Kamrul Hasan
Veröffentlicht: (2022)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
von: Mirza, Maisa Tasnim
Veröffentlicht: (2023)

Role of toll-like receptors in cancer immunotherapy– a review
von: Khan, Rezia Nowrin
Veröffentlicht: (2021)

In silico analysis revealed hsa-miR-19a-3p and hsa-miR-19b-3p as two potential inhibitors of EGF mRNA in Breast Cancer
von: Nuha, Nabiha Tahsin
Veröffentlicht: (2024)

Role of statins as antagonists of SPARC in gastric cancer
von: Shahmat, Rad
Veröffentlicht: (2019)

A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
von: Sorno, Rubina Haque
Veröffentlicht: (2024)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
von: Ratu, Tabassum
Veröffentlicht: (2024)

A review on bispecific antibody (blinatumomab) for the treatment of acute lymphoblastic leukemia
von: Choki, Kinley
Veröffentlicht: (2024)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
von: Razna, Amrin Islam
Veröffentlicht: (2019)

A comprehensive review on drug repurposing in cancer treatment
von: Sarkar, Onusree
Veröffentlicht: (2024)

A review on RNAi technology and its therapeutic potential in Cancer
von: Mahaleka, Aarshi
Veröffentlicht: (2024)

Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
von: Shaikat, Mahdi Mubin
Veröffentlicht: (2023)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
von: Hasan, Sakib
Veröffentlicht: (2024)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
von: Nawar, Anika
Veröffentlicht: (2019)

Statistics and informatics in molecular cancer research

Identification of FAP inhibitors using in silico simulation study
von: Deeba, Maliha Tasnim
Veröffentlicht: (2018)

Targeting BRAFV600E in the treatment of CRC
von: Roja, Mashwiyat Samrin
Veröffentlicht: (2024)

Targeted therapeutic options in the treatment of Breast Cancer
von: Alam, Kazi Tasnuva
Veröffentlicht: (2022)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
von: Rahman, Sanjida
Veröffentlicht: (2024)

Biosimilar in lymphoma treatment
von: Tanisha, Mehrin Haque
Veröffentlicht: (2021)

Current practice and approaches of immunotherapy in Cancer treatment
von: Khondokar, Faiza
Veröffentlicht: (2022)

A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
von: Islam, Nahidul
Veröffentlicht: (2023)

A review on Single Nucleotide Polymorphism (SNPs) and their effect on cancer risk in South Asian population
von: Beruni, Sajid Mahmud Al
Veröffentlicht: (2022)

Oncogenes: new targets in cancer treatment
von: Chowdhury, Waseka Shams
Veröffentlicht: (2020)

Potential phytochemicals and dietary components for the prevention and treatment of skin cancer: A review
von: Muntaha, Habibatul
Veröffentlicht: (2023)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
von: Haque, Mushfiqul
Veröffentlicht: (2019)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
von: Karim, Samia Binte
Veröffentlicht: (2024)